IL143181A0 - Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system - Google Patents

Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Info

Publication number
IL143181A0
IL143181A0 IL14318199A IL14318199A IL143181A0 IL 143181 A0 IL143181 A0 IL 143181A0 IL 14318199 A IL14318199 A IL 14318199A IL 14318199 A IL14318199 A IL 14318199A IL 143181 A0 IL143181 A0 IL 143181A0
Authority
IL
Israel
Prior art keywords
nervous system
central nervous
treating diseases
azabicycloalkane derivatives
substituted
Prior art date
Application number
IL14318199A
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL143181A0 publication Critical patent/IL143181A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14318199A 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system IL143181A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19854147A DE19854147A1 (en) 1998-11-24 1998-11-24 Control of cocaine addiction comprises administration of N-substituted azabicycloalkane derivative
PCT/EP1999/008734 WO2000030639A1 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Publications (1)

Publication Number Publication Date
IL143181A0 true IL143181A0 (en) 2002-04-21

Family

ID=7888824

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14318199A IL143181A0 (en) 1998-11-24 1999-11-12 Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system

Country Status (21)

Country Link
EP (1) EP1133293A1 (en)
JP (1) JP2002530333A (en)
KR (1) KR20010080535A (en)
CN (1) CN1328455A (en)
AR (1) AR021502A1 (en)
AU (1) AU1775300A (en)
BG (1) BG105549A (en)
BR (1) BR9915589A (en)
CA (1) CA2352526A1 (en)
CZ (1) CZ20011796A3 (en)
DE (1) DE19854147A1 (en)
HK (1) HK1040933A1 (en)
HR (1) HRP20010472A2 (en)
HU (1) HUP0104416A3 (en)
IL (1) IL143181A0 (en)
NO (1) NO20012538L (en)
PL (1) PL348758A1 (en)
SK (1) SK7112001A3 (en)
TR (1) TR200101476T2 (en)
WO (1) WO2000030639A1 (en)
ZA (1) ZA200103976B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0519013A2 (en) 2004-12-13 2009-11-03 Lilly Co Eli single compound or stereoisomers, mixtures of pharmaceutically acceptable stereoisomers, salts, tautomers or prodrugs thereof, pharmaceutical composition, and use of a compound
GB0812310D0 (en) 2008-07-03 2008-08-13 Syngenta Ltd Novel herbicides
WO2014111837A1 (en) * 2013-01-15 2014-07-24 Novartis Ag Use of alpha 7 nicotinic acetylcholine receptor agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348460A4 (en) * 1987-11-12 1991-11-27 American Home Products Corporation Polycyclicamines with psychotropic activity
DE4427648A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-Stubstituted 3-azabicyclo [3,2,0,] heptane derivatives, their preparation and use
DE4341403A1 (en) * 1993-12-04 1995-06-08 Basf Ag N-substituted 3-azabicycloalkane derivatives, their preparation and use
DE4427647A1 (en) * 1994-08-04 1996-02-08 Basf Ag N-substituted azabicycloheptane derivatives, their preparation and use

Also Published As

Publication number Publication date
CZ20011796A3 (en) 2002-05-15
KR20010080535A (en) 2001-08-22
WO2000030639A1 (en) 2000-06-02
BR9915589A (en) 2001-08-07
NO20012538L (en) 2001-07-04
HK1040933A1 (en) 2002-06-28
CA2352526A1 (en) 2000-06-02
PL348758A1 (en) 2002-06-03
HUP0104416A2 (en) 2002-04-29
NO20012538D0 (en) 2001-05-23
AR021502A1 (en) 2002-07-24
JP2002530333A (en) 2002-09-17
SK7112001A3 (en) 2001-12-03
AU1775300A (en) 2000-06-13
EP1133293A1 (en) 2001-09-19
HRP20010472A2 (en) 2003-04-30
CN1328455A (en) 2001-12-26
BG105549A (en) 2001-12-29
DE19854147A1 (en) 2000-05-25
ZA200103976B (en) 2002-05-16
TR200101476T2 (en) 2001-10-22
HUP0104416A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
GB2305605B (en) Pipecolic acid derivatives for the treatment of neurological disorders
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL139591A0 (en) Combination therapy for treatment of bipolar disorders
IL138129A (en) Composition for therapy of estrogen-associated disorders
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
PL350679A1 (en) Derivatives of 1-arenosulphonyl-2-arylpyrolydine and piperidine for treating central nervous system disorders
IL141263A0 (en) Methods for treatment of neurological disorders
SI0908458T1 (en) Substituted pyridylmethylpiperazine and piperidine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
EP1207874A4 (en) Methods of treating proliferative disorders
AU7788500A (en) Use of substance p antagonists for influencing the circadian timing system
EE200000391A (en) Triazine compounds for the treatment of central nervous system disorders
HUP0104701A3 (en) 3-tetrahydropyridin-4-yl indoles for treatment of psychotic disorders and medicaments containing the compounds
ATE256126T1 (en) 5-HETEROATOM-ALKYL SUBSTITUTED 3-OXO-PYRIDO(1,2-A)BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
HK1038510B (en) Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
PL348758A1 (en) Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system
HUP9902167A3 (en) Use of phenylnaphthalene derivatives to make medicaments for treating diseases of the central nervous system
IL135994A0 (en) Combination therapy for the treatment of aids
IL136949A0 (en) 1,4-diazacycloheptane derivatives for the treatment of neurological disorders
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
GB0010496D0 (en) Treatment of conditions of the central nervous system
GB9901808D0 (en) Drugs for treatment of psychiatric and brain disorders
GB9821610D0 (en) Treatment of neuropsychiatric disorders
GB9923551D0 (en) Treatment of neuropsychiatric disorders
SI1133290T1 (en) Use of inhibitors of acetylcholinesterase for the treatment of deliriums
UA25221A (en) METHOD OF TREATMENT OF DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Legal Events

Date Code Title Description
HP Change in proprietorship